Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure.

by Patricia van den Hoogen, Saskia C A de Jager, Emma A Mol, Arjan S Schoneveld, Manon M H Huibers, Aryan Vink, Pieter A Doevendans, Jon D Laman, Joost P G Sluijter
Published 2019-01-01